Maze Therapeutics Appoints Sekar Kathiresan, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that Sekar Kathiresan, M.D., a Maze co-founder, has joined the company’s board of directors. Dr. Kathiresan is an experienced cardiologist, co-founder and chief executive officer of Verve Therapeutics, and a lecturer in medicine at Harvard Medical School. His … [Read more…]
